{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T22:35:31Z","timestamp":1784932531103,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100011821","name":"Ministry of Education - Kingdom of Saudi Arabia","doi-asserted-by":"publisher","award":["IFKSUDR_H206"],"award-info":[{"award-number":["IFKSUDR_H206"]}],"id":[{"id":"10.13039\/501100011821","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-85502-4","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T09:41:05Z","timestamp":1738143665000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comprehensive computational analysis of differentially expressed miRNAs and their influence on transcriptomic signatures in prostate cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Fahad M.","family":"Aldakheel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadeel","family":"Alnajran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Mateen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shatha A.","family":"Alduraywish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed S.","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabbani","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"85502_CR1","doi-asserted-by":"crossref","unstructured":"Liadi, Y. et al. Prostate cancer Metastasis and Health Disparities: A Systematic Review (Prostate Cancer Prostatic Dis, 2023).","DOI":"10.1038\/s41391-023-00667-1"},{"issue":"9","key":"85502_CR2","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1586\/14737159.2015.1069183","volume":"15","author":"H Schwarzenbach","year":"2015","unstructured":"Schwarzenbach, H. The clinical relevance of circulating, exosomal miRNAs as biomarkers for cancer. Expert Rev. Mol. Diagn. 15 (9), 1159\u20131169 (2015).","journal-title":"Expert Rev. Mol. Diagn."},{"issue":"7","key":"85502_CR3","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3390\/genes14071375","volume":"14","author":"A Chakrabortty","year":"2023","unstructured":"Chakrabortty, A. et al. miRNAs: Potential as biomarkers and therapeutic targets for cancer. Genes 14 (7), 1375 (2023).","journal-title":"Genes"},{"issue":"3","key":"85502_CR4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/1878-0261.13329","volume":"17","author":"L Schneider","year":"2023","unstructured":"Schneider, L. et al. Post-prostatic-massage urine exosomes of men with chronic prostatitis\/chronic pelvic pain syndrome carry prostate-cancer-typical microRNAs and activate proto-oncogenes. Mol. Oncol. 17 (3), 445\u2013468 (2023).","journal-title":"Mol. Oncol."},{"key":"85502_CR5","doi-asserted-by":"publisher","first-page":"1066118","DOI":"10.3389\/fgene.2022.1066118","volume":"13","author":"T Shinawi","year":"2022","unstructured":"Shinawi, T. et al. A comparative mRNA- and miRNA transcriptomics reveals novel molecular signatures associated with metastatic prostate cancers. Front. Genet. 13, 1066118 (2022).","journal-title":"Front. Genet."},{"issue":"3","key":"85502_CR6","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/ijc.25376","volume":"128","author":"JC Brase","year":"2011","unstructured":"Brase, J. C. et al. Circulating miRNAs are correlated with tumor progression in prostate cancer. Int. J. Cancer. 128 (3), 608\u2013616 (2011).","journal-title":"Int. J. Cancer"},{"issue":"6","key":"85502_CR7","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/bjc.2016.233","volume":"115","author":"K Stuopelyte","year":"2016","unstructured":"Stuopelyte, K. et al. The utility of urine-circulating miRNAs for detection of prostate cancer. Br. J. Cancer. 115 (6), 707\u2013715 (2016).","journal-title":"Br. J. Cancer"},{"issue":"1","key":"85502_CR8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12967-019-1920-5","volume":"17","author":"C Hoey","year":"2019","unstructured":"Hoey, C. et al. Circulating miRNAs as non-invasive biomarkers to predict aggressive prostate cancer after radical prostatectomy. J. Translational Med. 17 (1), 173 (2019).","journal-title":"J. Translational Med."},{"issue":"36","key":"85502_CR9","doi-asserted-by":"publisher","first-page":"e16705","DOI":"10.1097\/MD.0000000000016705","volume":"98","author":"CW Bi","year":"2019","unstructured":"Bi, C. W. et al. Increased expression of miR-153 predicts poor prognosis for patients with prostate cancer. Med. (Baltim). 98 (36), e16705 (2019).","journal-title":"Med. (Baltim)."},{"issue":"18","key":"85502_CR10","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1038\/onc.2015.295","volume":"35","author":"C Coarfa","year":"2016","unstructured":"Coarfa, C. et al. Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer. Oncogene 35 (18), 2345\u20132356 (2016).","journal-title":"Oncogene"},{"issue":"3","key":"85502_CR11","doi-asserted-by":"publisher","first-page":"532","DOI":"10.23736\/S0026-4806.21.07478-4","volume":"113","author":"AI Bima","year":"2022","unstructured":"Bima, A. I. et al. Integrative global co-expression analysis identifies key microRNA-target gene networks as key blood biomarkers for obesity. Minerva Med. 113 (3), 532\u2013541 (2022).","journal-title":"Minerva Med."},{"issue":"Database issue","key":"85502_CR12","first-page":"D991","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett, T. et al. NCBI GEO: archive for functional genomics data sets\u2013update. Nucleic Acids Res. 41 (Database issue), D991\u2013D995 (2013).","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"85502_CR13","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43 (7), e47 (2015).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"85502_CR14","doi-asserted-by":"publisher","first-page":"D222","DOI":"10.1093\/nar\/gkab1079","volume":"50","author":"HY Huang","year":"2022","unstructured":"Huang, H. Y. et al. miRTarBase update 2022: an informative resource for experimentally validated miRNA-target interactions. Nucleic Acids Res. 50 (D1), D222\u2013d230 (2022).","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"85502_CR15","doi-asserted-by":"publisher","first-page":"D687","DOI":"10.1093\/nar\/gkab1028","volume":"50","author":"M Gillespie","year":"2022","unstructured":"Gillespie, M. et al. The reactome pathway knowledgebase 2022. Nucleic Acids Res. 50 (D1), D687\u2013d692 (2022).","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"85502_CR16","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin, C. H. et al. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst. Biol. 8 (4), S11 (2014).","journal-title":"BMC Syst. Biol."},{"issue":"8","key":"85502_CR17","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","volume":"25","author":"G Bindea","year":"2009","unstructured":"Bindea, G. et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 25 (8), 1091\u20131093 (2009).","journal-title":"Bioinformatics"},{"key":"85502_CR18","doi-asserted-by":"publisher","first-page":"985897","DOI":"10.3389\/fonc.2022.985897","volume":"12","author":"S Yousefnia","year":"2022","unstructured":"Yousefnia, S. A comprehensive review on miR-153: mechanistic and controversial roles of miR-153 in tumorigenicity of cancer cells. Front. Oncol. 12, 985897 (2022).","journal-title":"Front. Oncol."},{"issue":"1","key":"85502_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ncrna.2022.10.002","volume":"8","author":"I Gilyazova","year":"2023","unstructured":"Gilyazova, I. et al. The potential of miR-153 as aggressive prostate cancer biomarker. Noncoding RNA Res. 8 (1), 53\u201359 (2023).","journal-title":"Noncoding RNA Res."},{"key":"85502_CR20","doi-asserted-by":"publisher","first-page":"153741","DOI":"10.1016\/j.prp.2021.153741","volume":"229","author":"P Kaushik","year":"2022","unstructured":"Kaushik, P. & Kumar, A. Emerging role and function of miR-198 in human health and diseases. Pathol. - Res. Pract. 229, 153741 (2022).","journal-title":"Pathol. - Res. Pract."},{"key":"85502_CR21","doi-asserted-by":"publisher","first-page":"114820","DOI":"10.1016\/j.biopha.2023.114820","volume":"163","author":"GK Subbaraj","year":"2023","unstructured":"Subbaraj, G. K. et al. Anti-angiogenic effect of nano-formulated water soluble kaempferol and combretastatin in an in vivo chick chorioallantoic membrane model and HUVEC cells. Biomed. Pharmacother. 163, 114820 (2023).","journal-title":"Biomed. Pharmacother"},{"issue":"3","key":"85502_CR22","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s10555-020-09883-w","volume":"39","author":"Y Jiramongkol","year":"2020","unstructured":"Jiramongkol, Y. & Lam, E. W. FOXO transcription factor family in cancer and metastasis. Cancer Metastasis Rev. 39 (3), 681\u2013709 (2020).","journal-title":"Cancer Metastasis Rev."},{"key":"85502_CR23","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.gene.2018.03.013","volume":"658","author":"Q Feng","year":"2018","unstructured":"Feng, Q., He, P. & Wang, Y. MicroRNA-223-3p regulates cell chemo-sensitivity by targeting FOXO3 in prostatic cancer. Gene 658, 152\u2013158 (2018).","journal-title":"Gene"},{"issue":"12","key":"85502_CR24","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1089\/dna.2015.3186","volume":"35","author":"X Kong","year":"2016","unstructured":"Kong, X. et al. microRNA-372 suppresses migration and invasion by targeting p65 in human prostate cancer cells. DNA Cell. Biol. 35 (12), 828\u2013835 (2016).","journal-title":"DNA Cell. Biol."},{"issue":"5","key":"85502_CR25","doi-asserted-by":"publisher","first-page":"e15991","DOI":"10.1016\/j.heliyon.2023.e15991","volume":"9","author":"F Tajik","year":"2023","unstructured":"Tajik, F. et al. MicroRNA-372 acts as a double-edged sword in human cancers. Heliyon 9 (5), e15991 (2023).","journal-title":"Heliyon"},{"key":"85502_CR26","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.3389\/fgene.2019.01163","volume":"10","author":"JSM Sabir","year":"2019","unstructured":"Sabir, J. S. M. et al. Dissecting the role of NF-\u03bab protein family and its regulators in rheumatoid arthritis using weighted gene co-expression network. Front. Genet. 10, 1163 (2019).","journal-title":"Front. Genet."},{"issue":"12","key":"85502_CR27","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.7150\/jca.13176","volume":"6","author":"CJ Wallis","year":"2015","unstructured":"Wallis, C. J. et al. MiR-182 is Associated with growth, migration and invasion in prostate cancer via suppression of FOXO1. J. Cancer. 6 (12), 1295\u20131305 (2015).","journal-title":"J. Cancer"},{"key":"85502_CR28","doi-asserted-by":"publisher","first-page":"115167","DOI":"10.1016\/j.biopha.2023.115167","volume":"165","author":"Y Lin","year":"2023","unstructured":"Lin, Y. et al. NFAT signaling dysregulation in cancer: Emerging roles in cancer stem cells. Biomed. Pharmacother. 165, 115167 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"85502_CR29","doi-asserted-by":"publisher","first-page":"106775","DOI":"10.1016\/j.phrs.2023.106775","volume":"194","author":"RR Al-Rashidi","year":"2023","unstructured":"Al-Rashidi, R. R. et al. Malignant function of nuclear factor-kappab axis in prostate cancer: molecular interactions and regulation by non-coding RNAs. Pharmacol. Res. 194, 106775 (2023).","journal-title":"Pharmacol. Res."},{"key":"85502_CR30","doi-asserted-by":"crossref","unstructured":"Lin, T. H. et al. Apelin promotes prostate Cancer metastasis by downregulating TIMP2 via increases in miR-106a-5p expression. Cells, 11(20). (2022).","DOI":"10.3390\/cells11203285"},{"issue":"3","key":"85502_CR31","doi-asserted-by":"publisher","first-page":"362","DOI":"10.21873\/cgp.20326","volume":"19","author":"M H\u00edve\u0161","year":"2022","unstructured":"H\u00edve\u0161, M. et al. Role of genetic variations in CDK2, CCNE1 and p27(KIP1) in prostate cancer. Cancer Genomics Proteom. 19 (3), 362\u2013371 (2022).","journal-title":"Cancer Genomics Proteom."},{"key":"85502_CR32","doi-asserted-by":"publisher","first-page":"1105173","DOI":"10.3389\/fgene.2022.1105173","volume":"13","author":"G Ajabnoor","year":"2022","unstructured":"Ajabnoor, G. et al. Computational approaches for discovering significant microRNAs, microRNA-mRNA regulatory pathways, and therapeutic protein targets in endometrial cancer. Front. Genet. 13, 1105173 (2022).","journal-title":"Front. Genet."},{"issue":"8","key":"85502_CR33","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1016\/j.celrep.2017.01.072","volume":"18","author":"S Karanika","year":"2017","unstructured":"Karanika, S. et al. Targeting DNA damage response in prostate cancer by inhibiting androgen receptor-CDC6-ATR-Chk1 signaling. Cell. Rep. 18 (8), 1970\u20131981 (2017).","journal-title":"Cell. Rep."},{"issue":"1","key":"85502_CR34","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1186\/s12885-020-07058-y","volume":"20","author":"MJ Bou-Dargham","year":"2020","unstructured":"Bou-Dargham, M. J. et al. Immune landscape of human prostate cancer: Immune evasion mechanisms and biomarkers for personalized immunotherapy. BMC Cancer. 20 (1), 572 (2020).","journal-title":"BMC Cancer"},{"issue":"10","key":"85502_CR35","doi-asserted-by":"publisher","first-page":"e0271262","DOI":"10.1371\/journal.pone.0271262","volume":"17","author":"NA Shaik","year":"2022","unstructured":"Shaik, N. A. et al. Identification of miRNA-mRNA-TFs regulatory network and crucial pathways involved in asthma through advanced systems biology approaches. PLoS One. 17 (10), e0271262 (2022).","journal-title":"PLoS One"},{"key":"85502_CR36","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3389\/fcell.2020.00201","volume":"8","author":"MDM Maldonado","year":"2020","unstructured":"Maldonado, M. D. M. et al. Targeting Rac and Cdc42 GEFs in metastatic cancer. Front. Cell. Dev. Biol. 8, 201 (2020).","journal-title":"Front. Cell. Dev. Biol."},{"issue":"2","key":"85502_CR37","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s10555-020-09873-y","volume":"39","author":"C Gauthier-Rouvi\u00e8re","year":"2020","unstructured":"Gauthier-Rouvi\u00e8re, C. et al. Flotillin membrane domains in cancer. Cancer Metastasis Rev. 39 (2), 361\u2013374 (2020).","journal-title":"Cancer Metastasis Rev."},{"key":"85502_CR38","doi-asserted-by":"publisher","first-page":"104570","DOI":"10.1016\/j.compbiomed.2021.104570","volume":"135","author":"B Banaganapalli","year":"2021","unstructured":"Banaganapalli, B. et al. Multilevel systems biology analysis of lung transcriptomics data identifies key miRNAs and potential miRNA target genes for SARS-CoV-2 infection. Comput. Biol. Med. 135, 104570 (2021).","journal-title":"Comput. Biol. Med."},{"issue":"3","key":"85502_CR39","first-page":"1997","volume":"19","author":"YJ Guo","year":"2020","unstructured":"Guo, Y. J. et al. ERK\/MAPK signalling pathway and tumorigenesis. Exp. Ther. Med. 19 (3), 1997\u20132007 (2020).","journal-title":"Exp. Ther. Med."},{"key":"85502_CR40","doi-asserted-by":"publisher","first-page":"837957","DOI":"10.3389\/fped.2022.837957","volume":"10","author":"H Mansour","year":"2022","unstructured":"Mansour, H. et al. Genome-wide association study-guided exome rare variant burden analysis identifies IL1R1 and CD3E as potential autoimmunity risk genes for celiac disease. Front. Pediatr. 10, 837957 (2022).","journal-title":"Front. Pediatr."},{"issue":"2","key":"85502_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/sci4020015","volume":"4","author":"V Singh","year":"2022","unstructured":"Singh, V. et al. Apoptosis and pharmacological therapies for targeting thereof for cancer therapeutics. Sci 4 (2), 15 (2022).","journal-title":"Sci"},{"key":"85502_CR42","doi-asserted-by":"publisher","first-page":"p8321400","DOI":"10.1155\/2021\/8321400","volume":"2021","author":"F Ran","year":"2021","unstructured":"Ran, F. et al. Inhibition of vascular smooth muscle and cancer cell proliferation by New VEGFR inhibitors and their Immunomodulator Effect: Design, synthesis, and Biological evaluation. Oxidative Med. Cell. Longev. 2021, p8321400 (2021).","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"6","key":"85502_CR43","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s10237-022-01648-4","volume":"21","author":"T Abdalrahman","year":"2022","unstructured":"Abdalrahman, T. & Checa, S. On the role of mechanical signals on sprouting angiogenesis through computer modeling approaches. Biomech. Model. Mechanobiol. 21 (6), 1623\u20131640 (2022).","journal-title":"Biomech. Model. Mechanobiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85502-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85502-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85502-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T09:42:43Z","timestamp":1738143763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85502-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["85502"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-85502-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"assertion":[{"value":"25 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This is an observational study. No ethical approval is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors have given their consent for the possible publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}}],"article-number":"3646"}}